Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RxEDO is a private U.S. healthcare services company focused on transparent pharmacy benefit management and prescription benefit administration. Founded in 2003, the company serves self-funded employers, health plans, insurers, and related organizations with a full-disclosure business model intended to simplify and reduce prescription benefit costs. Its offerings include commercial pharmacy benefit administration, Medicare Part D support, CMS compliance services, formulary and utilization management, pharmacy network administration, and related claims-processing capabilities. RxEDO also markets proprietary analytical tools such as RxeEvaluate for historical claims repricing and comparison, and RxeAssure for post-transition review and savings analysis. The company appears to operate as a service and platform business rather than a drug developer, so it does not have a traditional biotech therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RxEDO.